QURE's three largest insider shareholders as of September 23, 2026 are Matthew C Kapusta (Ceo, Managing Director, 519.23K shares), Christian Klemt (Chief Financial Officer, 226.58K shares), Ricardo Dolmetsch (President, Rd, 163.40K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Matthew C Kapusta | Ceo, Managing Director | 519,227 | 0 | 519,227 | 29.2% | 07 Jul, 2026 |
| 2 | Christian Klemt | Chief Financial Officer | 226,581 | 0 | 226,581 | 12.7% | 06 Mar, 2026 |
| 3 | Ricardo Dolmetsch | President, Rd | 163,404 | 0 | 163,404 | 9.2% | 20 Sep, 2023 |
| 4 | Walid Abi-Saab | Chief Medical Officer | 148,235 | 0 | 148,235 | 8.3% | 02 Jul, 2026 |
| 5 | Jeannette Potts | Chief Legal Officer | 133,246 | 0 | 133,246 | 7.5% | 17 Jun, 2026 |
| 6 | Pierre Caloz | Chief Operating Officer | 115,707 | 0 | 115,707 | 6.5% | 20 Jun, 2024 |
| 7 | Kylie O'Keefe | Chief Customer Strat Officer | 108,864 | 0 | 108,864 | 6.1% | 12 Jun, 2026 |
| 8 | Alexander Edward Iii Kuta | Executive Vp, Operations | 90,381 | 0 | 90,381 | 5.1% | 09 Mar, 2023 |
| 9 | Madhavan Balachandran | Director | 43,254 | 0 | 43,254 | 2.4% | 22 Jun, 2026 |
| 10 | Jeremy P. Springhorn | Director | 43,251 | 0 | 43,251 | 2.4% | 12 Jun, 2026 |
| 11 | David D. Meek | Director | 39,747 | 0 | 39,747 | 2.2% | 12 Jun, 2026 |
| 12 | Leonard E Post | Director | 35,494 | 0 | 35,494 | 2.0% | 12 Jun, 2026 |
| 13 | Rachelle Suzanne Jacques | Director | 33,903 | 0 | 33,903 | 1.9% | 12 Jun, 2026 |
| 14 | Robert Gut | Chief Medical Officer | 32,259 | 0 | 32,259 | 1.8% | 12 Jun, 2026 |
| 15 | Jack Kaye | Director | 25,996 | 0 | 25,996 | 1.5% | 02 Jul, 2026 |
| 16 | Paula Soteropoulos | Director | 20,203 | 0 | 20,203 | 1.1% | 17 Jun, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 02 Jul, 2026 | Matthew C Kapusta | Ceo, Managing Director | Acquired M | 21,082 | $19.39 | $408.78K | 540,309 | Direct |
| 02 Jul, 2026 | Matthew C Kapusta | Ceo, Managing Director | Disposed S | 9,200 | $44.43 | $408.76K | 531,109 | Direct |
| 02 Jul, 2026 | Matthew C Kapusta | Ceo, Managing Director | Disposed S | 4,282 | $45.43 | $194.53K | 526,827 | Direct |
| 02 Jul, 2026 | Matthew C Kapusta | Ceo, Managing Director | Disposed S | 7,600 | $45.89 | $348.76K | 519,227 | Direct |
| 02 Jul, 2026 | Matthew C Kapusta | Ceo, Managing Director | Disposed M | 21,082 | $0.00 | $0 | 0 | Direct |
| 30 Jun, 2026 | Jack Kaye | Director | Acquired M | 4,107 | $37.00 | $151.96K | 30,103 | Direct |
| 30 Jun, 2026 | Walid Abi-Saab | Chief Medical Officer | Acquired M | 10,000 | $5.59 | $55.90K | 178,235 | Direct |
| 30 Jun, 2026 | Walid Abi-Saab | Chief Medical Officer | Disposed S | 10,000 | $46.46 | $464.60K | 168,235 | Direct |
| 30 Jun, 2026 | Jack Kaye | Director | Disposed S | 4,107 | $46.49 | $190.93K | 25,996 | Direct |
| 30 Jun, 2026 | Walid Abi-Saab | Chief Medical Officer | Disposed S | 20,000 | $46.40 | $928.00K | 148,235 | Direct |
| 30 Jun, 2026 | Jack Kaye | Director | Acquired M | 17,060 | $20.18 | $344.27K | 43,056 | Direct |
| 30 Jun, 2026 | Walid Abi-Saab | Chief Medical Officer | Disposed M | 10,000 | $0.00 | $0 | 50,500 | Direct |
| 30 Jun, 2026 | Jack Kaye | Director | Disposed S | 17,060 | $46.43 | $792.10K | 25,996 | Direct |
| 30 Jun, 2026 | Jack Kaye | Director | Disposed M | 4,107 | $0.00 | $0 | 0 | Direct |
| 30 Jun, 2026 | Jack Kaye | Director | Disposed M | 17,060 | $0.00 | $0 | 0 | Direct |
| 26 Jun, 2026 | Walid Abi-Saab | Chief Medical Officer | Disposed S | 1,434 | $46.86 | $67.20K | 168,235 | Direct |
| 24 Jun, 2026 | Matthew C Kapusta | Ceo, Managing Director | Acquired M | 4,128 | $31.71 | $130.90K | 525,923 | Direct |
| 24 Jun, 2026 | Matthew C Kapusta | Ceo, Managing Director | Disposed S | 6,696 | $50.00 | $334.80K | 519,227 | Direct |
| 25 Jun, 2026 | Matthew C Kapusta | Ceo, Managing Director | Acquired M | 28,716 | $31.71 | $910.58K | 547,943 | Direct |
| 25 Jun, 2026 | Matthew C Kapusta | Ceo, Managing Director | Disposed S | 28,716 | $50.02 | $1.44Mn | 519,227 | Direct |